Oracle hit a major financial milestone this week, reporting its strongest quarter in company history. For the fourth quarter of fiscal year 2026, the tech giant posted a record-breaking $19.2 billion in total revenue, marking a impressive 21% increase compared to the same period last year. Despite these stellar top-line results and non-GAAP earnings of $2.11 per share—which comfortably beat analyst estimates—investor reaction was swift and skeptical. By the end of after-hours trading, Oracle shares had dipped as Wall Street grappled with the massive, ballooning costs required to sustain this AI-driven growth.
The primary point of friction for investors is the company’s staggering capital expenditure. To fuel its skyrocketing demand for cloud infrastructure, Oracle reported an annual capital spend of $55.7 billion. This massive investment in data centers and AI hardware caused the company’s annual free cash flow to drop into negative territory, ending the fiscal year at a deficit of $23.7 billion. While Oracle’s revenue growth remains tied to the explosive 93% surge in its Cloud Infrastructure (IaaS) segment, the market is beginning to question the sustainability of this “spend-to-grow” business model.
Adding to the unease is Oracle’s aggressive approach to financing. During fiscal year 2026, the company raised $48 billion in new debt and equity to keep its momentum going. Looking ahead, management signaled plans to raise another $40 billion in fiscal 2027. This consistent need for external funding, combined with a total debt load now reaching $162 billion, has left many shareholders feeling anxious about the long-term balance sheet health of the company, even as cloud demand remains at record highs.
Oracle’s remaining performance obligations (RPO)—a key metric representing signed but unfulfilled contracts—skyrocketed to $638 billion, a 363% increase year-over-year. A significant portion of this backlog is tied directly to the AI arms race, with major deals involving partners like OpenAI. To manage the immense hardware demand, Oracle has pioneered an “outcome-based” model where customers prepay for GPU capacity or supply their own hardware. This strategy has already secured $75 billion in commitments, which helps offset some of the direct capital costs, though the sheer scale of the operation remains daunting.
Despite the stock price pullback, Oracle’s operational results show no signs of cooling. The company reaffirmed its ambitious target of $90 billion in revenue for fiscal year 2027 and continues to expand its reach into specialized verticals. New AI-powered systems for clinical drug discovery and patient care management in the healthcare sector are already gaining traction. Oracle’s leadership remains confident that these investments will cement its position as a primary backbone for global AI workloads.
For now, the battle between “growth at any cost” and “fiscal discipline” is defining Oracle’s market narrative. While the company is clearly winning the race to sign massive, multi-year AI infrastructure contracts, the market is demanding proof that these investments will eventually translate into consistent, positive free cash flow. As investors digest the record figures, the focus shifts to whether Oracle can balance its role as a premier AI utility provider with the necessity of stabilizing its financial position in the coming quarters.
